Last reviewed · How we verify
Test: Metronidazole Gel 1%
Metronidazole gel 1% works by killing bacteria and other microorganisms that cause infections.
Metronidazole gel 1% works by killing bacteria and other microorganisms that cause infections. Used for Treatment of rosacea, Treatment of acne.
At a glance
| Generic name | Test: Metronidazole Gel 1% |
|---|---|
| Sponsor | bioRASI, LLC |
| Drug class | nitroimidazole antibiotic |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
It does this by interfering with the DNA of these microorganisms, ultimately leading to their death. This is particularly useful for treating infections such as rosacea and acne.
Approved indications
- Treatment of rosacea
- Treatment of acne
Common side effects
- Skin irritation
- Dryness
- Redness
Key clinical trials
- Local and Systemic Antimicrobials in Non-surgical Periodontal Therapy (NA)
- Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application (PHASE4)
- Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV) (PHASE1)
- A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Test: Metronidazole Gel 1% CI brief — competitive landscape report
- Test: Metronidazole Gel 1% updates RSS · CI watch RSS
- bioRASI, LLC portfolio CI